BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 23, 2021
View Archived Issues
CaroGen to advance development of its novel immunotherapy candidate
Read More
First patients enrolled in IMPROVE-DiCE study of IMB-101
Read More
Neurona Therapeutics to advance its neural network-rebalancing cell therapies
Read More
Positive topline data from phase I study of emricasan in patients with mild symptomatic COVID-19
Read More
Augmenta and TFF select first lead monoclonal antibody candidate against COVID-19
Read More
Phase I dose-escalation data presented for BI-907828 in advanced solid tumors
Read More
Taiho Pharmaceutical and Astex Therapeutics patent GTPase KRAS inhibitors
Read More
Theravance Biopharma presents JAK3 inhibitors
Read More
Captor Therapeutics identifies new CRBN-targeting compounds
Read More
Lupin synthesizes new SOS1 inhibitors
Read More
NP-G2-044 shows safety and preliminary antitumor activity in phase I study
Read More
DTx Pharma presents new compounds for DMD
Read More
POLQ is next target for DNA damage response
Read More
New generation of antifungal membrane active peptides from combinatorial library screening
Read More
Gemini reports data from ongoing phase IIa study on GEM-103 in GA secondary to dry AMD
Read More
Sosei opens phase I trial of CGRP receptor antagonist HTL-0022562
Read More
RASSF1A and PRSS21 are diagnostic markers of TGCT
Read More
Tiziana prepares for phase II trial of intranasal foralumab in severe COVID-19
Read More
Keros reports preliminary phase II data on KER-050 for MDS
Read More
miR-126-3p has potential for diagnosing Parkinson's disease
Read More
New phase I trial studies DCP-001 in high-grade serous ovarian cancer
Read More
uniQure agrees to acquire Corlieve Therapeutics and lead gene therapy program
Read More
New phase I trial explores use of TLX250-CDx in bladder cancer
Read More
Aleta and Cancer Research UK collaborate on first-in-human study of ALETA-001
Read More
FDA clears IND for clinical evaluation of CLBS-201 for diabetic kidney disease
Read More